PHEX

If you have unexplained low blood phosphate, bone pain that started in childhood, bowed legs, repeated dental abscesses, or a family history of rickets that did not respond to vitamin D, the answer often lives in a single gene. Testing PHEX (phosphate-regulating endopeptidase X-linked) can confirm whether the underlying problem is X-linked hypophosphatemia, the most common inherited form of phosphate wasting.

This is not a screening test for the general population. It is a precision tool for a specific question: is your low phosphate, short stature, or skeletal deformity caused by a fault in the gene that controls how your kidneys hold onto phosphate? A confirmed answer changes how you are treated, who in your family gets evaluated, and which therapies you qualify for.

What PHEX Does in Your Body

PHEX codes for a zinc-dependent endopeptidase, a protein-cutting enzyme that sits on the surface of bone-forming cells (osteoblasts), bone-maintaining cells (osteocytes), and tooth-forming cells (odontoblasts). When PHEX works normally, it helps keep a hormone called FGF23 (fibroblast growth factor 23) in check. FGF23 tells your kidneys to dump phosphate into your urine.

When PHEX is broken, FGF23 climbs too high. Your kidneys then waste phosphate, your blood phosphate drops, and your body cannot build or maintain bone properly. The result is rickets in children and osteomalacia (soft bones) in adults. PHEX also appears to help your parathyroid glands sense phosphate, which is why people with PHEX-related disease often develop secondary or tertiary hyperparathyroidism (overactive parathyroid glands) over time.

X-Linked Hypophosphatemia, the Main Condition PHEX Detects

X-linked hypophosphatemia (XLH) is the dominant clinical reason this test exists. It is an X-linked dominant disorder, meaning a single faulty copy of the gene is enough to cause disease, and it can be passed from either parent to children. Hundreds of different loss-of-function variants have been identified across the gene, including missense, nonsense, frameshift, splice site, and large deletion mutations.

In a large sponsored testing program of people with clinical suspicion of genetic hypophosphatemia, PHEX variants accounted for the majority of confirmed X-linked hypophosphatemia diagnoses. In familial cases of hypophosphatemic rickets, PHEX mutations are found in roughly 87 percent of pedigrees, and in about 72 percent of sporadic cases with no obvious family history. If you have biochemically confirmed phosphate wasting, the odds that PHEX is the cause are high.

What Confirmation Changes for You

A confirmed PHEX variant is the gateway to burosumab, a monoclonal antibody that blocks excess FGF23 and is the first targeted therapy for X-linked hypophosphatemia. In a phase 3 trial in adults, burosumab corrected blood phosphate, reduced pain and stiffness, and improved bone health. In pediatric trials, it improved rickets severity scores and growth more effectively than the older approach of phosphate salts plus active vitamin D. Without genetic confirmation, you may be left on conventional therapy that can drive nephrocalcinosis (calcium deposits in the kidneys) and hyperparathyroidism without restoring normal phosphate.

Genotype Does Not Reliably Predict Severity

A common assumption is that the worse the mutation, the worse the disease. The evidence is more complicated. Multiple cohorts have found no clean correlation between the category of mutation (truncating versus non-truncating) and how severe the rickets, growth delay, or biochemical findings end up being.

What does correlate is residual enzyme function. People with variants that preserve some catalytic activity, or that leave the zinc-binding pocket intact, tend to have milder disease than those whose protein is completely nonfunctional. The takeaway: knowing you have a PHEX variant tells you the diagnosis, but your trajectory depends on residual function, sex, age at treatment, and other factors.

Mild and Adult-Onset Forms

Some PHEX variants cause unusually mild disease and can be missed for decades. A specific variant in the 3 prime UTR (untranslated region) of the gene, written c.*231A>G, produces a strikingly mild form, especially in girls and women, with higher phosphate and lower FGF23 than typical X-linked hypophosphatemia. People with this variant may be told their labs are nearly normal even when they are not.

PHEX mutations can also surface in adulthood. A novel loss-of-function variant called Ala720Ser was identified in an adult with hypophosphatemic osteomalacia and no childhood history of rickets, initially mimicking tumor-induced osteomalacia. If you are an adult with unexplained soft-bone disease and no tumor is found, genetic testing of PHEX is worth pursuing.

Why Mutation Type Alone Does Not Tell the Whole Story

The picture above can feel paradoxical: severe-sounding mutations sometimes produce milder disease, while subtle synonymous or deep intronic changes can produce classic rickets. The framework that resolves this is that PHEX is best understood as a continuum of residual enzyme activity, not as a simple on/off switch. A truncating mutation in a part of the protein that does not affect the zinc-binding catalytic core may leave more function intact than a single amino acid swap inside that core. Your phenotype reflects how much working enzyme your bone and tooth cells actually have, not the category your mutation falls into.

Adult Complications Worth Knowing

In adult cohorts followed at single centers, PHEX-related disease has been associated with osteoporosis, dental abscesses, nephrocalcinosis, hearing impairment, and a high need for orthopedic surgery including joint replacement. A Dutch cohort also reported high rates of adiposity, hearing loss, bone deformities, osteoarthritis, and hyperparathyroidism. The disease does not stop at growth plate closure. Confirming the gene early gives you a roadmap for the surveillance that follows.

What Your Result Should Trigger Next

A positive PHEX result is rarely the end of a workup. It opens the next set of questions: how severe is the biochemistry, how much bone damage has accumulated, and who else in your family needs evaluation? Pair the genetic result with serum phosphate, FGF23, calcium, alkaline phosphatase (ALP), parathyroid hormone (PTH), 1,25-dihydroxyvitamin D, urine calcium, and a renal ultrasound to look for nephrocalcinosis. A skeletal survey and DEXA scan provide baseline structural information. Refer to a metabolic bone specialist or endocrinologist familiar with X-linked hypophosphatemia to discuss whether burosumab is appropriate.

If the result is negative but your phosphate wasting is real, the workup is not finished. Deep intronic and noncoding PHEX variants have been missed by standard panels in families with classic disease and were only found with whole-genome sequencing, RNA studies, or multiplex ligation-dependent probe amplification. If suspicion remains high, expanded testing is the next step. Other genes such as FGF23, DMP1, ENPP1, and SLC34A3 can produce similar phenotypes and should be evaluated.

Family Cascade Testing

Because PHEX is X-linked dominant, a confirmed variant in you has direct implications for your children, siblings, and parents. Affected fathers pass the variant to all of their daughters and none of their sons. Affected mothers pass it to roughly half of their children regardless of sex. Cascade testing of relatives is high-yield: in published family series more than half of tested relatives carry the variant, often with milder or previously unrecognized disease. Identifying carriers in childhood is the most reliable way to prevent the bowed legs, dental abscesses, and short stature that come from delayed treatment.

Why This Test Is Different From a Phosphate Panel

A standard metabolic panel can show low phosphate, but it cannot tell you why. Low phosphate has many causes including nutritional deficiency, vitamin D problems, certain cancers (tumor-induced osteomalacia), inherited disorders involving other genes, and medication side effects. PHEX testing answers a specific question that no biochemical test can answer alone: is this a heritable, lifelong condition that will affect your children, demand specific therapy, and require lifelong surveillance? Once you have a PHEX result, biochemistry takes over for monitoring. The genetic answer itself does not change with time.